Drugs / hokt3g1 (ALA-ALA)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00073255 | Jun 2003 → Dec 2005 | type 1 diabetes mellitus | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hokt3g1 (ALA-ALA) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00073255 ↗ |
| Route | Intravenous | “administered via intravenous infusion” NCT00073255 ↗ |